For p53 mutations, the sequence is reversed, with p53 loss of heterozygosity as an early event in colitis-associated CRC and a much later event in the adenoma-carcinoma sequence of sporadic CRC (77, 80). This evidence concerns the gene TP53 and colorectal carcinoma.